These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3543093)

  • 1. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
    Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
    Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of intravenous indoramin on the hemodynamic adaptation at rest and during exercise in chronic congestive heart failure.
    De Kock MR; Detry JM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S107-11. PubMed ID: 2423782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of indoramin on exercise performance in mild hypertension.
    Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoramin in severe congestive heart failure.
    Grube E; Manz M; Lüderitz B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S117-23. PubMed ID: 2423784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
    Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
    Good AP; Unverferth DV; Leier CV
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness].
    Grube E; Lauven GW; Manz M; Lüderitz B
    Dtsch Med Wochenschr; 1986 Mar; 111(11):416-20. PubMed ID: 3948703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in angina pectoris with alpha adrenoceptor blockade.
    Collins P; Sheridan D
    Br Heart J; 1985 May; 53(5):488-92. PubMed ID: 2859870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
    Bennett JM; Weich DJ; Schoeman HS
    S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.
    Kassis E; Amtorp O; Waldorff S; Fritz-Hansen P
    Br Heart J; 1987 Nov; 58(5):505-11. PubMed ID: 3314956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ; Thomas P; Culling W; Collins P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
    Franciosa JA; Jordan RA; Wilen MM; Leddy CL
    Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.